drugset / Trial / NCT02907073

Positron Emission Tomography (PET) Imaging Studies With NIS Reporter

NCT02907073 ↗

Phase 1/2 Terminated 8 enrolled Mayo Clinic
Non-randomizedFactorialOpen-labelDiagnostic

Summary

The goal of this proposal is to perform first-in-man evaluation of and experimental imaging agent F-18 tetrafluoroborate (BF4) or (TFB).

Timeline

Start
2016-09
Primary completion
2017-12
Completion
2017-12

Outcome

Outcome not reported

Stopped: “pursuing IND”

Drugs

EvaluationDrugModalityDoseRoute
Subject BF4 Diagnostic / imaging agent — Intravenous